Bioteque Corporation (TPEX:4107)

Market Cap	8.28B -2.4%
Revenue (ttm)	2.07B -0.7%
Net Income	517.86M +3.7%
EPS	7.44 +3.8%
Shares Out	69.30M
PE Ratio	16.06
Forward PE	14.99
Dividend	5.00 (4.18%)
Ex-Dividend Date	Jul 28, 2025

Volume	58,189
Average Volume	58,582
Open	120.50
Previous Close	120.00
Day's Range	119.00 - 120.50
52-Week Range	101.00 - 133.50
Beta	0.13
RSI	44.06
Earnings Date	Mar 12, 2026

About Bioteque

Bioteque Corporation manufactures and sells medical device in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine co...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2024, Bioteque's revenue was 2.07 billion, an increase of 6.58% compared to the previous year's 1.94 billion. Earnings were 528.26 million, an increase of 16.73%.